Literature DB >> 2245385

Diffuse sclerosing variant of papillary carcinoma of the thyroid. Clinical importance, surgical treatment, and follow-up study.

Y Fujimoto1, T Obara, Y Ito, T Kodama, M Aiba, K Yamaguchi.   

Abstract

A diffuse sclerosing variant is not very rare among papillary carcinomas of the thyroid when the patients are female and younger than 30 years of age. The variant is characterized by diffuse involvement of one or both thyroid lobes, with dense sclerosis, patchy lymphocytic infiltration, and abundant psammoma bodies. Controversy still exists concerning its prognosis. We reviewed our experience with 14 patients treated between 1958 and 1988. All patients were young females, their age being from 10 to 28 years with a mean of 19.6. Hashimoto's thyroiditis had been suspected in nine patients before they came to our clinic. Nowadays the diagnosis of this cancer is possible when we have this entity in mind and detect abundant psammoma bodies either by ultrasonography or by soft-tissue roentgenography of the neck. Total thyroidectomy with modified neck dissection was carried out in eight patients, subtotal thyroidectomy with neck dissection in five, and lobectomy with neck dissection in one. All of them are alive and well without distant metastasis at a mean follow-up of 16 years. Because most of the patients with this variant of papillary carcinoma are young women and the prognosis is favorable, a complete resection without causing later recurrence, but also cosmetic and complication-free surgery, should be considered.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2245385     DOI: 10.1002/1097-0142(19901201)66:11<2306::aid-cncr2820661109>3.0.co;2-p

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  16 in total

1.  An unusual presentation of diffuse sclerosing variant of papillary thyroid carcinoma.

Authors:  C Regalbuto; A Tumminia; P Malandrino; S Salamone; V Pezzino
Journal:  J Endocrinol Invest       Date:  2010-06       Impact factor: 4.256

2.  Diffuse sclerosing variant of papillary thyroid carcinoma: a clinicopathologic and immunophenotypic analysis of 22 cases.

Authors:  Lester D R Thompson; Jacqueline A Wieneke; Clara S Heffess
Journal:  Endocr Pathol       Date:  2005       Impact factor: 3.943

3.  Leu-M 1 immunoreactivity in papillary carcinomas of the thyroid gland; microcarcinoma, encapsulated, conventional and diffuse sclerosing subtypes.

Authors:  M Alejo; G Peiro; E Oliva; X Matias-Guiu
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1991

4.  A case with diffuse sclerosing variant of papillary carcinoma of the thyroid: characteristic features on ultrasonography.

Authors:  Kaoru Kobayashi; Shuji Fukata; Nobuyuki Amino; Akira Miyauchi
Journal:  J Med Ultrason (2001)       Date:  2006-09       Impact factor: 1.314

5.  Clinicopathologic features and outcomes in patients with diffuse sclerosing variant of papillary thyroid carcinoma.

Authors:  Junko Akaishi; Kiminori Sugino; Kaori Kameyama; Chie Masaki; Kenichi Matsuzu; Akifumi Suzuki; Takashi Uruno; Keiko Ohkuwa; Hiroshi Shibuya; Wataru Kitagawa; Mitsuji Nagahama; Kazuo Shimizu; Koichi Ito
Journal:  World J Surg       Date:  2015-07       Impact factor: 3.352

6.  Papillary thyroid carcinoma of a diffuse sclerosing variant: ultrasonographic monitoring from a normal thyroid gland to mass formation.

Authors:  Hye Seong Kim; Boo-Kyung Han; Jung Hee Shin; Eun Young Ko; Chang Ohk Sung; Young Lyun Oh; Sang Yong Song
Journal:  Korean J Radiol       Date:  2010-08-27       Impact factor: 3.500

7.  Aggressive variants of papillary thyroid microcarcinoma are associated with extrathyroidal spread and lymph-node metastases: a population-level analysis.

Authors:  Eric J Kuo; Paolo Goffredo; Julie A Sosa; Sanziana A Roman
Journal:  Thyroid       Date:  2013-09-14       Impact factor: 6.568

8.  TGFB, TGFB Receptors, Ki-67, and p27(Kip)l Expression in Papillary Thyroid Carcinomas.

Authors:  Ricardo V. Lloyd; Jorge A. Ferreiro; Long Jin; Tom J. Sebo
Journal:  Endocr Pathol       Date:  1997       Impact factor: 3.943

9.  Simultaneous diffuse sclerosis variant of papillary thyroid carcinoma and diffuse toxic hyperplasia (Graves' disease).

Authors:  Gladell P Paner; Jennifer L Hunt; Marlyn C Ciesla; Steven DeJong; Virginia LiVolsi
Journal:  Endocr Pathol       Date:  2004       Impact factor: 3.943

10.  Multiple brain metastases from a diffuse sclerosing variant of papillary carcinoma of the thyroid.

Authors:  Y Imamura; Y Kasahara; M Fukuda
Journal:  Endocr Pathol       Date:  2000       Impact factor: 3.943

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.